TEST 2 Flashcards
what is important to know about simple masks
5-10 LPM
30-55% FiO2 (not exact)
can be humidified
must have 5+ LPM to prevent rebreathing
uses and contraindications of simple mask
uses- non acute situation
mild hypoxia
contraindications- needs below 5LPM
acute respiratory distress
Severe hypoxia
what is important to know about non-rebreather mask
10-15 LPM (high flow)
80-100% FiO2
unable to be humidified
reservoir bag MUST be inflated
Uses and contraindications of non-rebreather mask
uses- acute respiratory distress
short term high oxygen needs
contraindications- long term use
what is important to know about venturi mask
2-15 LPM
24-50% FiO2
prevents over oxygenation
different colors designed for exact FiO2
can be humidified
uses and contraindications of venturi mask
uses- underlying lung disease
contraindications- O2 needs over 50% FiO2
what is important to know about nasal cannula
1-6 LPM
24-45% FiO2
can be humidified
uses and contraindications of nasal cannula
uses- non acute situation
mild hypoxia
mouth breathing
contraindications- acute resp distress
severe hypoxia
mouth breathing
** i dont understand how mouth breathing is a use and a contraindication but thats what her poster says)
what is important to know about trach masks
5-15 LPM
35-90% FiO2
minimum of 5L required to prevent rebreathing
must be humidified
if O2 is not needed, compressed air with humidification is used
uses and contraindications of trach masks
uses- delivery of humidification and O2
for trach patients (duh??)
contraindications
patients without a trach (is this a joke)
what is important to know about 1/2 mask/face tent/shovel mask and what are the uses
5-15 LPM
35-50% FiO2
uses- delivery of higher amounts of humidification
postop oral/nasal surgery
Risk factors for TB
close contact with someone w/ active tb
immigration from other countries w/ a high prevalence(southeast asia, africa)
institutionalism (close proximity)
living in overcrowded, substandard housing
caring for immunosuppressed patients
exposure during high risk procedures
what groups of people are at risk for tb
immunocompromised (most at risk)
substance abusers
inadequate healthcare( homeless, minorities)
pre-existing medical conditions
clinical manifestations of tb
Cough lasting 3 weeks or longer
Hemoptysis
Sputum production
Weakness
Fatigue
Anorexia, weight loss
Low-gradefever, chills
Night sweats
Pleuritic chest pain
how is tb diagnosed
mantoux test (PPD)- skin test
ntiFERON-TB Gold (QFT-G)- blood test
sputum smear- Presence of AFB(acid fact bacteria) on a sputum smear may indicate disease but does not confirm the diagnosis
sputum culture- gold standard for diagnosis
chest x ray- lesions will be visible
ct thorax- show extent of damage to lung tissue
CBC- elevated WBC
non pharmacological treatment for tb
rest initially
well balanced high calorie diet
smoking cessation
pharmacological treatment for tb
pulmonary tb- Anti-TB agents (antibiotic) 6 to 12 months
administer humidified oxygen as prescribed
what are the most common tb antibiotics
rifampin(RIF)
isoniazid (INH)
pyrazinamide(PZA)
ethambutol(EMB)
all are bactericidal but work on different parts of bacilli
remember RIPE for the meds names
what is tb
Primarily infection of lung parenchyma
-Leads to impaired gas exchange
-May be transmitted and infect other areas of the body: meninges, kidneys, bones, lymph nodes and GI tract.
- infectious agent is M. tuberculosis
what do we teach patient to report with each tb antibiotic
rifampin(RIF)
isoniazid (INH)
pyrazinamide(PZA)
ethambutol(EMB)
rifampin(RIF)- orange urine/secretions, report jaundice, pain, swelling joints, anorexia, malaise
isoniazid (INH)- report s/s of hepatotoxicity, jaundice, malaise, anorexia, nausea, fatigue
pyrazinamide(PZA)-report jaundice, pain, swelling joints, anorexia, malaise
ethambutol(EMB)- report changes in vision
rifampin & pyrazinamide have the same s/s to report
what is the medication regimen for newly diagnosed active tb
all 4 oral antibiotics for the first 2 months
followed by an additional 4 months of rifampin and isoniazid
what is primary drug resistance in regards to tb
Resistance to one of the first line anti-TB agents in people who have not had previous treatment
what is secondary or acquired drug resistance in regards to tb
Resistance to one or more anti-TB agents in patients undergoing therapy
what is multidrug resistance in regards to tb
Resistance to two agents, isoniazid (INH) and rifampin. The populations at greatest risk for multidrug resistance are those who are HIV positive, institutionalized, or homeless.